Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mannkind Corp
(NQ:
MNKD
)
6.260
-0.070 (-1.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mannkind Corp
< Previous
1
2
3
4
Next >
7 Overvalued Penny Stocks to Sell Before June 2023
May 28, 2023
It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable.
Via
InvestorPlace
3 Biotech Stocks to Avoid Like the Plague
May 23, 2023
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.
Via
InvestorPlace
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
Via
Benzinga
Why Shares of MannKind Are Up Wednesday
May 10, 2023
The company released its first-quarter earnings report on Tuesday.
Via
The Motley Fool
MannKind (MNKD) Q1 2023 Earnings Call Transcript
May 09, 2023
MNKD earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
May 10, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
MannKind: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market
April 16, 2023
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at...
Via
Talk Markets
Looking Into MannKind's Return On Capital Employed
February 27, 2023
Via
Benzinga
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
February 27, 2023
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...
Via
Benzinga
MannKind (MNKD) Q4 2022 Earnings Call Transcript
February 24, 2023
MNKD earnings call for the period ending December 31, 2022.
Via
The Motley Fool
MannKind Earnings Preview
February 22, 2023
Via
Benzinga
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 20, 2023
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...
Via
Benzinga
Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday
February 24, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
MannKind's Return On Capital Employed Overview
December 05, 2022
Via
Benzinga
MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
November 08, 2022
MNKD earnings call for the period ending September 30, 2022.
Via
The Motley Fool
MannKind: Q2 Earnings Insights
August 09, 2022
MannKind (NASDAQ:MNKD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
3 Biotech Stocks Under $15 Worth a Second Look in 2023
January 18, 2023
All three stocks have promising therapies that could drive revenue in the coming years.
Via
The Motley Fool
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
November 09, 2022
Via
Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
November 09, 2022
B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading.
Via
Benzinga
Earnings Preview: MannKind
November 07, 2022
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...
Via
Benzinga
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
September 29, 2022
While these market ideas are risky, they offer enough relevance to be intriguing.
Via
InvestorPlace
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
MannKind Shares Fall After Completing Initial Stage Lung Disease Study
September 06, 2022
MannKind Corporation (NASDAQ: MNKD) has successfully completed a Phase 1 study of clofazimine inhalation suspension (MNKD 101), an inhalation treatment option for nontuberculous mycobacterial (NTM)...
Via
Benzinga
Earnings Outlook For MannKind
August 08, 2022
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...
Via
Benzinga
Jim Cramer Recommends Selling This Stock: 'No One Ever Likes Me To Say Anything Bad' About This Company
August 04, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Canoo Inc. (NASDAQ: GOEV) is losing money. "We’re done with those stocks that just lose money," he added.
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
May 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
Via
InvestorPlace
MannKind Earnings Preview
May 04, 2022
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.